JAMA Netw Open 2022 Feb 01
Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade.
Related Questions
Do you have a BMI threshold where you would convert to weight-based dosing over flat dosing? Are certain agents of more or less concern - PD-1, PD-L1,...
New answer by Medical Oncologist at Fox Chase Cancer Center (September 8, 2022)
No, we do not have a BMI threshold at our institution. PD-1, PD-L1 are continued as flat doses; occasionally CTLA4 inhibitors might be dosed as weight based, using adjusted we...